General Information:

Id: 8,495 (click here to show other Interactions for entry)
Diseases: Major depressive disorder - [OMIM]
Rattus norvegicus
male
article
Reference: Wen C et al.(2015) Urine metabolomics in rats after administration of ketamine Drug Des Devel Ther 9: 717-722 [PMID: 25678776]

Interaction Information:

Comment In this study a urine metabonomic method was developed, based on gas chromatography-mass spectrometry (GC-MS), to evaluate the effect of ketamine on rats. Compared with the control group, at day 7, the level of alanine, butanoic acid, glutamine, butanedioic, trimethylsiloxy, L-aspartic acid, D-glucose, cholesterol, acetamide, and oleic acid of the ketamine group was increased, while the level of 2,3,4-trihydroxybutyric acid, benzeneacetic acid, threitol, ribitol, xylitol, and glycine decreased. At day 14, the level of alanine, ethanedioic acid, L-proline, glycerol, tetradecanoic acid, l-serine, l-phenylalanine, L-aspartic acid, d-glucose, cholesterol, heptadecanoic acid, and acetamide in rat urine of the ketamine group was increased, while the 2,3,4-trihydroxybutyric acid, benzeneacetic acid, d-ribose, threitol, ribitol, glycine, pyrazine, and oleic acid levels decreased. The results indicate that metabonomic methods based on GC-MS may be useful to elucidate ketamine abuse, through the exploration of biomarkers.
Formal Description
Interaction-ID: 87023

drug/chemical compound

Ketamine

increases_quantity of

drug/chemical compound

Aspartate

in urine; at day 7, at day 14
Drugbank entries Show/Hide entries for Ketamine